Arrowhead Research | Betriebsaufwand



Operating Expenses Veränderung Datum
Agios Pharmaceuticals USD 139.51M 24.16M 2025-06
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Arrowhead Research USD 193.32M 31.81M 2025-06
Incyte USD 904.7M 56.97M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
Ligand Pharmaceuticals USD 40.46M 41.09M 2025-06
Merck USD 9.44B 217M 2025-06
Moderna USD 1.04B 113M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
TG Therapeutics USD 106.3M 5.93M 2025-06
Ultragenyx Pharmaceutical USD 274.38M 7.85M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06
Xencor USD 76.78M 865K 2025-06


Arrowhead Research Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.